| 1 |
A tutorial on particle filters for online nonlinear/non-Gaussian Bayesian tracking
M.S. Arulampalam, Simon R. Maskell, Neil Gordon et al. · IEEE Transactions on Signal Processing
|
2002 |
11,594 |
| 2 |
FinnGen provides genetic insights from a well-phenotyped isolated population
Mitja Kurki et al. · Nature
Open access169 authors |
18 Jan 2023 |
4,362 |
| 3 |
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models
Michael Hucka et al. · Bioinformatics
Open access |
28 Feb 2003 |
3,190 |
| 4 |
The support of human genetic evidence for approved drug indications
Matthew R. Nelson, Hannah Tipney, Jeffery L. Painter et al. · Nature Genetics
|
29 Jun 2015 |
1,812 |
| 5 |
Plasma proteomic associations with genetics and health in the UK Biobank
Benjamin B. Sun et al. · Nature
Open access |
4 Oct 2023 |
1,716 |
| 6 |
Organic synthesis provides opportunities to transform drug discovery
David C. Blakemore, Luis C. Misal Castro, Ian Churcher et al. · Nature Chemistry
|
22 Mar 2018 |
1,554 |
| 7 |
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Michael J. Waring, John E. Arrowsmith, Andrew R. Leach et al. · Nature Reviews Drug Discovery
Review |
19 Jun 2015 |
1,467 |
| 8 |
Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling
Joanna C. Betts, Pauline T. Lukey, Linda C. Robb et al. · Molecular Microbiology
Open access |
Feb 2002 |
1,426 |
| 9 |
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al. · Nature Chemical Biology
Open access |
10 Jun 2015 |
1,365 |
| 10 |
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi et al. · Science
Open access |
12 Jul 2013 |
1,207 |
| 11 |
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Maureen P. Martin, Xiaojiang Gao, Jeong-Hee Lee et al. · Nature Genetics
|
22 Jul 2002 |
1,196 |
| 12 |
Expanding GSK's solvent selection guide – embedding sustainability into solvent selection starting at medicinal chemistry
Richard K. Henderson, Concepción Jiménez‐González, David J. C. Constable et al. · Green Chemistry
|
2011 |
1,140 |
| 13 |
Mapping the human genetic architecture of COVID-19
COVID-19 Host Genetics Initiative et al. · Nature
Open access3,896 authors |
8 Jul 2021 |
1,130 |
| 14 |
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
Frieda A. Koopman, Sangeeta S. Chavan, S. Miljko et al. · Proceedings of the National Academy of Sciences
Open access |
5 Jul 2016 |
1,049 |
| 15 |
Updating and further expanding GSK's solvent sustainability guide
Catherine M. Alder, John D. Hayler, Richard K. Henderson et al. · Green Chemistry
|
2016 |
1,045 |
| 16 |
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics
Joanne T. Brindle, Henrik Antti, Elaine C. Holmes et al. · Nature Medicine
|
25 Nov 2002 |
997 |
| 17 |
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
Laurens Kruidenier et al. · Nature
Open access |
27 Jul 2012 |
975 |
| 18 |
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al. · Nature
|
19 Dec 2018 |
954 |
| 19 |
Resistin is expressed in human macrophages and directly regulated by PPARγ activators
Lisa Patel, Amy C Buckels, Ian J. Kinghorn et al. · Biochemical and Biophysical Research Communications
|
2003 |
928 |
| 20 |
Proteomics: quantitative and physical mapping of cellular proteins
Walter P. Blackstock, Malcolm Weir · Trends in biotechnology
Review |
Mar 1999 |
873 |
| 21 |
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
Jie Zheng et al. · Nature Genetics
Open access |
7 Sep 2020 |
854 |
| 22 |
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
Huw D. Lewis et al. · Nature Chemical Biology
Open access |
26 Jan 2015 |
792 |
| 23 |
Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics
Maya Ghoussaini et al. · Nucleic Acids Research
Open access |
17 Sep 2020 |
717 |
| 24 |
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I. Swerdlow et al. · The Lancet
Open access133 authors |
24 Sep 2014 |
713 |
| 25 |
An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People
Matthew R. Nelson et al. · Science
Open access |
18 May 2012 |
707 |
| 26 |
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
Michael Vaclav Holmes et al. · BMJ
Open access155 authors |
10 Jul 2014 |
689 |
| 27 |
Cleavable linkers in antibody–drug conjugates
Jonathan D. Bargh, Albert Isidro‐Llobet, Jeremy S. Parker et al. · Chemical Society Reviews
Review |
2019 |
659 |
| 28 |
Membranes for the dehydration of solvents by pervaporation
Peter D. Chapman, Teresa A.C. Oliveira, Andrew Guy Livingston et al. · Journal of Membrane Science
|
10 Mar 2008 |
647 |
| 29 |
Exome sequencing and characterization of 49,960 individuals in the UK Biobank
Cristopher V. Van Hout et al. · Nature
Open access |
21 Oct 2020 |
637 |
| 30 |
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
Akram Khan, Cody Benthin, Brian R. Zeno et al. · Critical Care
Open access |
5 Sep 2017 |
634 |
| 31 |
Financial Strain over the Life Course and Health among Older Adults
Joan R. Kahn, Leonard I. Pearlin · Journal of Health and Social Behavior
|
Mar 2006 |
632 |
| 32 |
International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Steven M. Foord, Tom I. Bonner, Richard R. Neubig et al. · Pharmacological Reviews
|
24 May 2005 |
620 |
| 33 |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries
Nick R. G. Shrine et al. · Nature Genetics
Open access110 authors |
25 Feb 2019 |
615 |
| 34 |
Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology
Manuel A. R. Ferreira et al. · Nature Genetics
Open access |
30 Oct 2017 |
585 |
| 35 |
Open Targets Platform: supporting systematic drug–target identification and prioritisation
David Ochoa et al. · Nucleic Acids Research
Open access |
11 Nov 2020 |
577 |
| 36 |
Emerging therapeutic opportunities for integrin inhibitors
Robert J. Slack, Simon J. F. Macdonald, James A. Roper et al. · Nature Reviews Drug Discovery
ReviewOpen access |
17 Sep 2021 |
574 |
| 37 |
Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes
Jeremy Schwartzentruber, Sarah Cooper, Jimmy Z. Liu et al. · Nature Genetics
Open access |
15 Feb 2021 |
572 |
| 38 |
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
Bettina Sandgathe Husebo, Clive G. Ballard, Reidun Karin Norheim Myhre Sandvik et al. · BMJ
Open access |
15 Jul 2011 |
570 |
| 39 |
Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
Kimberly Burns, Jonathan Clatworthy, Laurence Martin et al. · Nature Cell Biology
|
10 May 2000 |
565 |
| 40 |
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Dominick E. Shaw et al. · European Respiratory Journal
Open access |
10 Sep 2015 |
564 |
| 41 |
Open Targets: a platform for therapeutic target identification and validation
Gautier Koscielny et al. · Nucleic Acids Research
Open access |
3 Nov 2016 |
553 |
| 42 |
Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data
Ioanna Tachmazidou et al. · Nature Genetics
Open access |
21 Jan 2019 |
551 |
| 43 |
Open Targets Platform: new developments and updates two years on
Denise Carvalho‐Silva, Andrea Pierleoni, Miguel Pignatelli et al. · Nucleic Acids Research
Open access |
26 Oct 2018 |
537 |
| 44 |
Pursuing the leadlikeness concept in pharmaceutical research
Mike Hann, Tudor Ionel Oprea · Current Opinion in Chemical Biology
Review |
8 May 2004 |
515 |
| 45 |
The 3D OrbiSIMS—label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power
Melissa K. Passarelli, Alexander Pirkl, Rudolf Moellers et al. · Nature Methods
Open access |
13 Nov 2017 |
482 |
| 46 |
Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in alzheimer's disease
Gemma Jones, Barbara Jacquelyn Sahakian, Roy Levy et al. · Psychopharmacology
|
Sep 1992 |
478 |
| 47 |
Site-selective modification strategies in antibody–drug conjugates
Stephen J. Walsh, Jonathan D. Bargh, Friederike M. Dannheim et al. · Chemical Society Reviews
ReviewOpen access |
10 Dec 2020 |
460 |
| 48 |
HIBAG—HLA genotype imputation with attribute bagging
Xiuwen Zheng, Judong Shen, Charles J. Cox et al. · The Pharmacogenomics Journal
Open access |
28 May 2013 |
458 |
| 49 |
A green chemistry perspective on catalytic amide bond formation
Marco T. Sabatini, Lee T. Boulton, Helen F. Sneddon et al. · Nature Catalysis
|
4 Jan 2019 |
436 |
| 50 |
Finding the sweet spot: the role of nature and nurture in medicinal chemistry
Michael M. Hann, György Miklós Keserű · Nature Reviews Drug Discovery
Review |
30 Apr 2012 |
421 |